Methods for De Novo Protein Sequencing

Patent №

US 11,047,863

Granted

2021-06-29

Filed 2019

Owner

REGENERON PHARMACEUTICALS, INC.

Lab

AI components

2

evo · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16542788

A method for determining an amino acid sequence of a polypeptide, including comprising: contacting a first sample containing the polypeptide with a first protease(e.g., Trypsin) to produce a first set of digested peptide fragments; fragmenting the first set of digested peptide fragments to produce a first set of fragmented peptide ions; determining masses of the first set of fragmented peptide ions; contacting a second sample containing the polypeptide with a second protease (e.g., Tryp-N); fragmenting the second set of digested peptide fragments to produce a second set of fragmented peptide ions; selecting pairs of peptide ions from the first and the second set of fragmented peptide ions that differ in mass by a mass of an arginine amino acid residue or a lysine amino acid residue; assigning an ion type (either N-terminal peptide ion or C-terminal peptide ion) to the selected pairs of the peptide ions from two sets of fragmented peptide ions;selecting a mass ladder of the same-type peptide ions in either set of fragmented peptide ions with incremental mass by the mass of amino acid residue(s), and assembling the identified amino acid residues from the mass ladder to determine the amino acid sequence of the polypeptide of interest.

Evolutionary computationAI hardwareG01N 33/6848G01N 33/6851C07K 16/065G16B 20/00G16B 40/10H01J 49/305

AI classification

Evolutionary computation0.98
AI hardware0.87
Natural language0.16
Knowledge representation0.09
Vision0.00
Speech0.00
Machine learning0.00
Planning0.00

Ownership

REGENERON PHARMACEUTICALS, INC.

assignment · 549510710

Assignors

MAO, YUAN

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC